Clinical Trial

Anesthesia Induction with the Target-controlled Infusion of Propofol in High-risk Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 3, 2025 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare the risk of hypotension following induction of anesthesia in high-risk patients (American Society of Anesthesiologists risk scores III and IV) using target-controlled infusion (TCI) of propofol versus standard manual induction of anesthesia. Our previously published study compared TCI and manual induction of anesthesia in a general patient population and found that hypotension developed less with TCI induction. This study is a continuation of the other study and will be conducted in high-risk patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-31; most recent amendment 2025-01-30.
Status change: Not Yet Recruiting → Recruiting 2024-09-18
Trial Details
NCT Number NCT06535230
Lead Sponsor Acibadem University
Conditions Anesthesia, Hemodynamic Instability
Enrollment 200 participants
Start Date 2024-08-30
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-03